$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How many times a day should linezolid (Siwo) tablets 600 mg be taken to meet the standard dosage requirements?
2026-02-01 22:25:32
Check Details
Whether ribociclib (Calilon) is strictly a targeted drug and a detailed analysis of its CDK4/6 inhibition mechanism
2026-02-01 22:25:32
Check Details
Is cemiplimab available in China and the status of its listing and channel availability in China
2026-02-01 22:25:32
Check Details
The latest progress of Daprodustat as well as global marketing trends and clinical research directions
2026-02-01 22:25:32
Check Details
Durvalumab (durvalumab) standard usage and dosage and instructions for individualized regimens for different patients
2026-02-01 22:25:32
Check Details
How long does the usual injection course of Zolbetuximab take and the factors that affect the length of the course?
2026-02-01 22:25:32
Check Details
How much does a box of EIKANCE 0.01% Atropine Sulfate Eye Drops cost in the market and the main factors affecting the price?
2026-02-01 22:25:32
Check Details
Analysis of common adverse reactions of Teritusumab/Telivac
2026-02-01 22:25:32
Check Details
Which company produces Bimetinib/Bemetinib?
2026-02-01 22:25:32
Check Details
How long does the effect of Upatinib/Ruifu last and what are the influencing factors?
2026-02-01 22:25:32
Check Details
Can nintedanib/Vigat cure pulmonary fibrosis and what is its clinical effect?
2026-02-01 22:25:32
Check Details
Bosutinib belongs to which generation of drugs
2026-02-01 22:25:32
Check Details
1
2
...
2406
2407
2408
2409
2410
2411
2412
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma